Detailed Study Notes on Natural Killer Cells and Immune Responses

Types of Cells in the Immune System

  • The immune system is composed of various cell types that work together to detect and eliminate pathogens and abnormal cells.

    • Complement and Granular Sites: Entities that assist in the immune response.

    • Natural Killer Cells (NK Cells): A crucial part of the innate immune response.

    • Act quickly upon pathogen introduction without needing prior sensitization.

Immune Response Phases

  • Innate Immune Response:

    • Fast-acting (minutes to hours)

    • Always present and ready to defend against infections, acting as first responders.

    • Operates through various mechanisms without a prior encounter with the pathogen.

    • NK cells can lyse (destroy) target cells with no previous exposure.

    • Germline-encoded receptors: NK cells detect abnormalities using these fixed receptors.

  • Adaptive Immune Response:

    • Slower (days to weeks) and offers a targeted response through antibodies and cellular immunity (e.g., B cells and T cells).

    • Produces specific antibodies post-sensitization, creating a memory for faster responses upon subsequent exposures.

    • Evidence suggests some overlap between innate and adaptive responses in functionality.

Function of Natural Killer Cells

  • Roles of NK Cells:

    • Cytotoxic Activity: Ability to destroy virally infected cells and early-stage tumor cells.

    • Operate effectively without prior training; they can recognize abnormal cells immediately.

    • Secretion of Cytokines and Chemokines: Involved in enhancing antiviral responses and recruiting other immune cells.

  • NK Cell Characteristics:

    • Constitute approximately 5% to 15% of lymphocytes in peripheral blood, varying based on individual health and infections.

    • Can engage in serial killing, where they destroy multiple target cells in succession.

Visual Representation of NK Cell Action

  • Video demonstration illustrates NK cells detecting and destroying cancer cells:

    • Cancer Cells are significantly larger than NK cells, which are small lymphocytes.

    • Sequence of NK cells surrounding cancer cells and executing their destruction through edge interactions.

Mechanism of NK Cell Activation

  • NK cells perform constant surveillance of body tissues to identify healthy versus abnormal cells:

    • Employ inhibitory signals that prevent unwanted killing of healthy cells, ensuring a safety mechanism in immune responses.

  • Evolutionary approach prioritizes cautious activation of a powerful cell type, guarding against collateral damage.

NK Cell Development

  • Development Stages:

    • Initiated from multipotent common lymphoid progenitor cells to NK-restricted progenitor cells.

    • Distinction in NK cell morphology and functionality between humans and mice, requiring specific markers for identification:

    • Markers: In mice, NK1.1; in humans, CD56.

  • CD56* Subpopulations:

    • Cells classified as bright (immature) and dim (more mature and functionally potent).

    • Flow cytometry separates NK cell subpopulations based on intensity of CD56 expression.

Receptors and Signaling Pathways in NK Cells

  • Transcription factors essential for NK cell function include T-BET and EOMES.

  • Receptor classification influences NK cell activation:

    • Activating Receptors: Induce NK cell function, responding to abnormal cells.

    • Inhibitory Receptors: Prevent activation upon recognizing healthy cell markers, e.g., MHC class I (Human version: HLA class I).

NK Cell Cytotoxic Mechanisms

  • NK cells utilize granules that contain proteins like granzymes to induce apoptosis in target cells.

    • Engagement of death receptors (e.g., Fas ligand and TRAIL) amplifies local signaling to trigger cell death processes.

    • Calls for redundancy in cytotoxic mechanisms: if one pathway fails, another can still operate effectively.

Cytokine and Chemokine System Interactions

  • NK cells modulate other immune cells (like dendritic cells and macrophages) by secreting cytokines that shape the broader immune landscape.

  • Antibody-Dependent Cellular Cytotoxicity (ADCC): Killer cells recognize antibodies bound to target antigens, engaging NK cell activators for targeted destruction.

Dynamics within the Tumor Microenvironment

  • Dendritic cells can uptake apoptotic tumor cells, which are crucial for activating T cells, leading to a robust immune response against tumors.

  • Challenges: Tumors can develop mechanisms to evade detection and destruction by both NK and T cells, including cytokine inhibition and lack of surface marker expression.

NK Cell Dysfunction and Therapy Implications

  • NK cells can become dysfunctional due to various factors, impacting cancer immunity efficacy.

  • The shift in CD56 bright/dim ratios correlates to tumor progression and recovery dynamics of immune response.

  • Studies indicate that higher NK cell activity correlates with better prognosis in treating cancers, emphasizing their role in countering malignancies.

  • Development of therapies targeting NK cell activation represents an ongoing area of research to enhance cancer treatment outcomes.

Conclusion

  • The diverse array of activating and inhibitory receptors on NK cells guides their response to abnormal cells, ensuring a balance in immune activation.

  • Insight into NK cell biology and functionality can inform future therapeutic strategies for enhancing immune responses against cancer and other diseases.